134 related articles for article (PubMed ID: 28498080)
1. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
3. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor expression in middle ear cholesteatoma.
Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
Kojima H; Shiwa M; Kamide Y; Moriyama H
Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
Li H; Jiang P; Wang L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
[TBL] [Abstract][Full Text] [Related]
7. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
[TBL] [Abstract][Full Text] [Related]
8. Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear.
Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Kakihana M; Shimano K; Terada N; Sakagami M
Auris Nasus Larynx; 2004 Mar; 31(1):3-9. PubMed ID: 15041047
[TBL] [Abstract][Full Text] [Related]
9. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
11. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
[TBL] [Abstract][Full Text] [Related]
13. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
Bujía J; Kim C; Holly A; Sudhoff H; Ostos P; Kastenbauer E
Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947
[TBL] [Abstract][Full Text] [Related]
15. Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.
Zhang L; Rice AB; Adler K; Sannes P; Martin L; Gladwell W; Koo JS; Gray TE; Bonner JC
Am J Respir Cell Mol Biol; 2001 Feb; 24(2):123-31. PubMed ID: 11159045
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins in middle ear cholesteatoma.
Shinoda H; Huang CC
Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
[TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
18. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
[TBL] [Abstract][Full Text] [Related]
19. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
